US healthcare group reports strong earnings but announces an $800m charge for legal costs associated with the recall of its metal-on-metal hip devices
Read more from Financial Times
US healthcare group reports strong earnings but announces an $800m charge for legal costs associated with the recall of its metal-on-metal hip devices